ArticleActa epileptologica2026
First corpus callosotomy for medically refractory epilepsy in The Gambia: an international cooperation case report and historical review.
Article in Acta epileptologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpilepsy affects over 50 million people worldwide, with the majority residing in low- and middle-income countries (LMICs) where access to specialized care is often constrained. Surgical intervention represents a crucial therapeutic modality for patients with medically refractory epilepsy, yet epilepsy surgery remains markedly underutilized in sub-Saharan Africa. CASE PRESENTATION: We report the case of a 10-year-old boy in The Gambia with medically refractory epilepsy characterized by daily drop attacks. Despite optimized and adequately trialed therapy with carbamazepine and sodium valproate, he continued to experience disabling seizures, leading to recurrent head trauma. Computed tomography (CT) and magnetic resonance imaging (MRI) did not reveal an identifiable structural lesion. Given the intractability of seizures and significant associated morbidity, he underwent a corpus callosotomy. The procedure was performed via a standard microsurgical approach and concurrently addressed the resection of traumatic calcified scalp hematomas. The patient's postoperative recovery was uneventful, and he was discharged on postoperative day 13 and remained seizure-free. At the six-month postoperative follow-up, the patient achieved complete freedom from drop attacks, with generalized tonic-clonic seizures (GTCS) occurring only during periods of antiseizure medication (ASM) interruption.
conclusionsThis case highlights the feasibility and therapeutic potential of epilepsy surgery in the context of a surgical program within a resource-limited setting. Scaling up access to epilepsy surgery in comparable environments could contribute to mitigating the global epilepsy treatment gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.